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Abstract
Background: Gaps in maternal and child health services can slow progress towards achieving the Sustainable
Development Goals. The Management and Optimization of Nutrition, Antenatal, Reproductive, Child Health & HIV
Care (MONARCH) study will evaluate a Continuous Quality Improvement (CQI) intervention targeted at improving
antenatal and postnatal health service outcomes in rural South Africa where HIV prevalence among pregnant
women is extremely high. Specifically, it will establish the effectiveness of CQI on viral load (VL) testing in pregnant
women who are HIV-positive and repeat HIV testing in pregnant women who are HIV-negative.
Methods: This is a stepped-wedge cluster-randomised controlled trial (RCT) of 7 nurse-led primary healthcare
clinics to establish the effect of CQI on selected routine antenatal and postnatal services. Each clinic was a cluster,
with the exception of the two smallest clinics, which jointly formed one cluster. The intervention was applied at the
cluster level, where staff received training on CQI methodology and additional mentoring as required. In the control
exposure state, the clusters received the South African Department of Health standard of care. After a baseline data
collection period of 2 months, the first cluster crossed over from control to intervention exposure state; subsequently, one
additional cluster crossed over every 2 months. The six clusters were divided into 3 groups by patient volume (low,
medium and high). We randomised the six clusters to the sequences of crossing over, such that both the first three and
the last three sequences included one cluster with low, one with medium, and one with high patient volume.
The primary outcome measures were (i) viral load testing among pregnant women who were HIV-positive, and (ii) repeat
HIV testing among pregnant women who were HIV-negative. Consenting women ≥18 years attending antenatal and
postnatal care during the data collection period completed outcome measures at delivery, and postpartum at three to 6
days, and 6 weeks. Data collection started on 15 July 2015. The total study duration, including pre- and post-exposure
phases, was 19 months. Data will be analyzed by intention-to-treat based on first booked clinic of study participants.
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Discussion: The results of the MONARCH trial will establish the effectiveness of CQI in improving antenatal and postnatal
clinic processes in primary care in sub-Saharan Africa. More generally, the results will contribute to our knowledge on
quality improvement interventions in resource-poor settings.
Trial registration: This trial was registered on 10 December 2015: www.clinicaltrials.gov, identifier NCT02626351.
Keywords: Health systems, Continuous quality improvement, Maternal, HIV, Stepped wedge, Randomised trial,
Background
South Africa has made considerable gains in improving
prevention of mother-to-child transmission of HIV
(PMTCT) services coverage since being identified as a
Global Plan Priority country in 2009 [1]. In 2012, nearly 4
million women in the country lived with HIV and ante-
natal HIV prevalence was 30% [2]. The PMTCT Cascade
of Care (CoC) refers to key steps in the clinical pathway
from early diagnosis of HIV in pregnancy/postpartum to
achieving long-term maternal HIV virologic suppression
on antiretroviral therapy (ART), retention-in-care, and
early infant diagnosis and treatment [3]. Leakages in the
PMTCT care cascade hinder progress towards eliminating
paediatric HIV and protecting maternal and child health.
Among pregnant women who are HIV-positive, HIV viral
load (VL) testing is critical to judge the clinical perfor-
mance of ART and to prevent vertical transmission of HIV
from mother to child [4, 5]. Vertical transmission risk
increases with maternal VL [6, 7]. VL testing can identify
virologic failure early, leading to timely interventions such
as adherence counselling, resistance testing and treatment
switches, and enhanced antiretroviral prophylaxis for
HIV-exposed infants [8]. Moreover, VL testing is important
because large proportions of pregnant women on ART are
failing virologically (by some estimates 20–40% [9, 10]).
The South African National PMTCT guidelines recom-
mend universal ART for pregnant women who are
HIV-positive and regular VL testing to monitor the clinical
performance of ART [11]. However, in many communities
in South Africa and other sub-Saharan African countries
the majority of pregnant women on ART, and
non-pregnant women and men, do not receive regular VL
tests [12–15].
Repeat HIV testing of pregnant women who are HIV-
negative is important because HIV incidence in pregnancy
is high in many countries [16]. In South Africa, HIV inci-
dence in pregnancy and postpartum is estimated to be
above 4% [10, 16]. Since VL increases markedly shortly
after infection, the risk of MTCT is particularly high
among recently infected women [17]. Early diagnosis of
HIV and initiation of ART are thus critical to ensure that
MTCT is eliminated, but this requires pregnant women
who are HIV-negative to be re-tested at regular intervals
[18]. The South African National PMTCT guidelines thus
recommend pregnant women who are HIV-negative to be
tested in three-monthly intervals after the initial HIV test
during the first antenatal visit [11]. However, in South
Africa and other countries in sub-Saharan Africa large
proportions of pregnant women who are HIV-negative do
not receive repeat HIV tests [17, 19, 20].
In addition to the need for improvements in early
diagnosis of HIV and regular VL monitoring of ART in
antenatal care, adherence to clinical guidelines and qual-
ity of care continue to be major challenges following
delivery in many countries [21, 22], undermining the
delivery of effective postnatal care to mothers and chil-
dren including ART, safe infant feeding and postnatal
contraception.
One important approach to improving quality of care in
the health sector is Continuous Quality Improvement (CQI)
[23, 24]. Several features of CQI make it an attractive choice
to improve quality of care and adherence to clinical guide-
lines in pregnancy-related care in sub-Saharan Africa. First,
CQI uses time-tested and robust management techniques to
diagnose quality problems, develop solutions and monitor
progress. These techniques can be adapted to improve many
different processes and healthcare functions, depending on
clinical contextual needs and opportunities for improvement
identified with real-time data [23, 24]. Second, CQI
empowers health workers to develop approaches and take
actions to improve quality of care on an ongoing basis. CQI
mentors work with local clinic staff to facilitate the develop-
ment of solutions to quality of care shortcomings that the
staff identify as best suited to their local contexts. Third,
CQI works within existing resource constraints and does
not require large long-term investments to ensure sustained
improvements in quality of care [25].
Several randomized controlled trials have demonstrated
that CQI initiatives can be successful in improving quality
of hospital care in resource-rich countries [26–28].
However, despite major CQI initiatives in primary care in
several sub-Saharan African countries [29–33], rigorous
scientific evidence on CQI effectiveness in these settings is
largely lacking.
The MONARCH stepped-wedge cluster RCT will for
the first time establish the effectiveness of an interven-
tion to improve VL testing in pregnant women who are
HIV-positive and repeat HIV testing in pregnant women
who are HIV-negative in primary care clinics in rural
South Africa.
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More broadly, the trial will contribute to our under-
standing of the effectiveness of CQI in improving the
quality of antenatal and postnatal care and add to the
scarce but growing evidence on the effectiveness of CQI
as an approach to improve quality of care in
sub-Saharan Africa [34, 35]. This evidence is important
because several governments in sub-Saharan Africa are
using CQI to improve quality of care in public-sector
healthcare provision [29–33].
Primary and secondary endpoints
Our primary endpoints are (i) viral load testing among
pregnant women who are HIV-positive and (ii) repeat
HIV testing among pregnant women who are HIV-nega-
tive. Our secondary endpoints are:
(i) Patient experiences of healthcare quality among all
pregnant women
(ii) Maternal health outcomes including:
a. Postnatal care attendance within 6 weeks
postpartum among all pregnant women
b. Maternal retention in HIV care among women
who are HIV-positive
c. ART utilization among women who are HIV-
positive
d. Maternal HIV virologic suppression among
women who are HIV-positive
e. HIV seroconversion in pregnancy among
women who are HIV-negative
(iii) Infant health outcomes including:
a. Mother-to-child transmission of HIV
b. Nevirapine prophylaxis for HIV-exposed infants
c. Infants with weight, length, and head
circumference measured
(iv)Maternal knowledge and uptake of key services
including:
a. HIV services
b. Contraceptive services
c. Exclusive breastfeeding
(v) Healthcare provider job satisfaction and motivation
Methods and design
Study setting and CQI implementation
The study setting is rural KwaZulu-Natal, South Africa,
in the community participating in the population health
research carried out by the Africa Health Research Insti-
tute (AHRI) which was previously known as the Africa
Centre for Health and Population Studies. AHRI is located
within a 438 km2 area in the mostly rural Hlabisa
sub-district of northern KwaZulu-Natal (Fig. 1). As a
Wellcome Trust-Howard Hughes Medical Institute major
overseas programme, the AHRI Population Intervention
Platform Surveillance Area (PIPSA) South has collected
comprehensive longitudinal population and HIV
surveillance data on consenting individuals ≥15 years old
(approximately 90,000 people in 11,000 households) since
2003. HIV prevalence amongst women of reproductive
age is ~ 37% [36]. Overall fertility has been stabile since
2000, at about three children per woman, with an average
of 2200 live births per year [37].
There are 6 nurse-led Department of Health (DoH)
primary healthcare clinics (PHCs) of varying size within
the geographic bounds of PIPSA South. The clinic im-
mediately outside the PIPSA South geographic bounds
located in the market town of Mtubatuba, adjoins a
major highway and is often visited by PIPSA residents
regardless of proximity. It was thus added to the 6
clinics within PIPSA South for this study. Oversight of
these 7 clinics is led by the local primary level
sub-district hospital, Hlabisa Hospital. Medical officer
support is provided weekly where possible.
The CQI intervention in this study was delivered by the
University of KwaZulu-Natal (UKZN) Centre for Rural
Health (CRH) CQI specialist team who travelled from
Durban, KwaZulu-Natal, to the study site. They worked
collaboratively with PHC staff to implement changes in
clinical practice through training and mentorship using
real-time clinic data. The CRH team consisted of two
isiZulu-speaking South African professional nurses (CRH
CQI mentors) and a data capturer who carried out field
activities, with close support from an Improvement Ad-
visor (a consultant obstetrician with CQI experience), a
Scientific Advisor and a data manager. CQI field activities
for the entire project were scheduled in advance of the
first intervention step and are described in detail below.
Study design
The study, a stepped-wedge cluster RCT, was carried
out from 15 July 2015 to 30 January 2017, at the 7 DoH
PHCs described above: Mtubatuba, KwaMsane, Mpuku-
nyoni, Somkhele, Machibini, Esiyembeni and Gunjaneni.
All clusters crossed over from control to intervention
exposure according to the stepped-wedge study design
(Fig. 2). The six clusters were randomised to the calen-
dar sequences of crossing over. The stepped-wedge
study design was selected because (i) it was considered
unethical to withhold the intervention from some clinics
as CQI has known efficacy in resource-rich settings; (ii)
the participation of all clinics both during the control
and the intervention exposure state was thought to be
better if it was known that during the course of the trial
all clinics would receive the intervention; (iii) the field
implementers of CQI were a small team of three
people, making simultaneous rollout in all clusters
impracticable; and (iv) it allows adjustment for secular
trends in outcomes. Data collection occurred at all 7
DoH PHCs and Hlabisa Hospital maternity ward as
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the majority of deliveries from the sub-district occur
at Hlabisa Hospital.
Eligibility criteria
Clusters
The clusters were pre-defined and included the 6 PHCs
within the PIPSA South area plus Mtubatuba clinic.
Antenatal care providers within clusters participated in
the CQI activities based on availability. Efforts were
made to recruit providers in leadership roles (e.g. Oper-
ational Managers, Professional Nurses) to increase likeli-
hood of sustainability of the intervention and
dissemination of skills. Based on clinic size (and staffing)
approximately five participants from each clinic
constituted a facility-level CQI team, which ideally in-
cluded at least one person in a leadership position.
Individuals
All women aged 18 years or older were overall eligible
for outcome and exposure assessment at three time
points independent of previous or prospective recruit-
ment status: at delivery, at the 3–6 day postnatal visit,
and at the 6-week postnatal visit. Recruitment occurred
continuously at all clinics and Hlabisa Hospital over the
entire study period regardless of the clinic’s randomisa-
tion status. Women who had just delivered a baby at
Hlabisa Hospital or any of the 7 study clinics were re-
cruited for outcome and exposure assessment if they
Fig. 1 The Africa Health Research Institute study site at Somkhele. Location of the MONARCH study. Based on: Tanser et al. 2008 [46]
Fig. 2 The MONARCH stepped wedge study design. Clinics provided baseline (pre-intervention) data until each rolled over to the intervention in
random order. All clinics provided data continuously throughout the study period. Baseline data collection across all clinics occurred from 15 July
2015 to 28 September 2015 (Step 0). As data extraction on antenatal visits was retrospective from the point of delivery, the baseline observation
period covered an additional ~ 6 months for the first recruited participants – thus Step 0 covered a duration of ~ 8 months
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had attended any of the 7 study clinics for antenatal care
(ANC) or resided in PIPSA South during their preg-
nancy. Consenting women attending a 3–6 day or
6-week postnatal visit at a study clinic with their infant
(aged < 8 days or 5–8 weeks respectively) were recruited
regardless of ANC clinic attended or where they resided
during pregnancy.
Procedures
Conceptual framework
We hypothesized that this CQI intervention would bring
about the desired changes in clinical processes by providing
a supportive and motivating environment alongside real-time
data to PHC-level healthcare providers. The CRH team sup-
ported PHC staff to implement simple workable solutions to
gaps identified through collaborative root-cause analyses.
Furthermore, CQI may have increased job satisfaction and
empowerment through reduced workload and better patient
outcomes. Implicit in these assumptions were staff availabi-
lity to participate in CQI activities and the ability to continue
normal clinical duties in parallel to CQI activities.
Intervention package
Each intervention step was of 2 months’ duration with a
2-month pre-exposure data collection period and a
4.5-month endline (Fig. 2). We refer to the first 2-month
intervention step as the ‘transition’ phase – this was the
start of the intervention, in which ‘intensive’ CQI was
delivered. The maintenance phase occurred after this
transition phase for each cluster and included support
and maintenance CQI visits in approximately monthly
intervals. Visit types and planned activities are described
in Table 1.
CQI field activities for the entire project were scheduled
in advance of the first intervention step. Clinic-based CQI
activities occurred over 3 days of a given week, and ad-
ministrative work scheduled for a separate day each week.
CQI tools and principles (Tables 1 & 2) included Action
Learning Sessions at the end of each transition phase to
consolidate skills and share experiences. The intervention
was based on the Institute for Healthcare Improvement
(IHI) breakthrough collaborative CQI model [38]. Given
time constraints imposed by the study design, activities
mainly targeted the primary endpoint indicators: repeat
HIV screening and HIV viral load (VL) testing according
to South African PMTCT guidelines (Additional file 1:
Text S1). Additional study endpoint indicators were
addressed as time permitted.
Prior to transition-phase CQI activities, a 2-week
lead-in period (approximately 4 visits) was planned, to
introduce the newly randomised cluster to the CRH
team and CQI concepts. A standardized ‘dose’ of inten-
sive CQI of ~ 19 visits, was planned for each transition
step. A schedule of monthly follow-up (CQI mainte-
nance) visits was also planned thereafter and varied by
cluster due to order of randomisation.
Efforts to prevent cross-contamination whilst enabling
buy-in for sustainability of CQI were made: only rando-
mised clinics were invited to attend Action Learning
Sessions, and PHC supervisors were excluded from these
events during the intervention period (unlike ‘real-world’
implementation of CQI) as they supervise multiple
clinics. However after the final transition step was
complete, a final joint Action Learning Session with staff
from all 7 clinics, PHC supervisors, sub-district and
district DoH staff was held. In order to reduce bias the
AHRI study investigators (evaluators) refrained from
intervening in CQI clinic processes, although some
operational co-involvement was required (e.g. introdu-
cing the CRH team to clinic staff ).
Table 1 Description of CQI intervention visit types and activities
Study phase Visit type Description of activities
Intensive CQI
(transition)
Induction • Introduction to the CRH QI team
• Situational analysis with preliminary appraisal of local clinic processes and pre-exposure data collection
using facility data sources such as registers
• Training of facility staff by CRH CQI mentors on CQI methodology and tools
Intervention • Mapping clinic processes and establishing priorities for process improvements through bottleneck and
root-cause analyses with standardized CQI tools such as process maps, fishbone diagrams, initiation of
PDSA cycles and run charts
• Implementing changes and monitoring progress through PDSA cycle reviews and run charts
Support • Mentorship, support and ongoing assistance to monitor progress and review changes via iterative
PDSA cycles and run charts
• Considering to adopt the implemented changes (Change Package)
Maintenance Support • Mentorship, support and ongoing assistance are provided to monitor progress and review changes
via iterative PDSA cycles and run charts
• Considering to adopt the implemented changes (Change Package)
Maintenance • As for Support visits
Action Learning Session • Sharing change ideas and experiences with other facilities already randomised to the intervention
CQI Continuous Quality Improvement, CRH Centre for Rural Health, PDSA Plan-Do-Study-Act
Chetty et al. BMC Health Services Research  (2018) 18:625 Page 5 of 10
Comparator
During the control exposure state, maternal and child
healthcare providers continued providing DoH standard
of care to ANC and PNC attendees as usually imple-
mented. The South African maternal and child health
strategic plan outlines the maternal package of services
to be provided, including basic antenatal care. Usual train-
ing for staff involves weekly 1 hour in-service training on
current evidence-based guidelines applied to primary
healthcare services and may include training on ANC or
PNC. The usual training, however, does not contain a
mentoring component and is not a data driven process to
evaluate the implementation of evidence-based guidelines.
Additional background details on DoH standard of care
are provided (Additional file 1: Text S1).
Data sources
All eligible women had their Maternity Case Record (MCR)
photographed at delivery, excluding the intrapartum section,
based on UKZN Biomedical Research Ethics Committee
waiver of requirement for consent to access routine DoH
data. All consenting women were interviewed at delivery
and their infant’s Road-to-Health Booklet (RtHB) photo-
graphed. The structured interview covered themes on
demographics, satisfaction with services, obstetric history,
pregnancy intention, healthcare expenditures, access to care,
and knowledge (infant feeding and HIV). At the 3–6 day
and 6-week postnatal visits all consenting women were
interviewed and their infant’s RtHB photographed. The
structured interview at the 3–6 day visit was identical to the
delivery visit. The 6-week structured interview covered
themes on demographics, satisfaction with services, know-
ledge and uptake of services (HIV, PMTCT services, adher-
ence to ART, contraception, self-reported infant feeding
practices), healthcare expenditures, and access to care. All
questionnaires contained questions in English with isiZulu
translations and were conducted in isiZulu.
Structured interviews of consenting healthcare providers
at the 7 study clinics were undertaken in English covering
themes on job satisfaction, motivation and antenatal care
practices, at study mid-point and study end.
Process evaluation data sources included semi-structured
healthcare provider interviews undertaken in English, and
detailed CQI implementation records from CRH for each
PHC. The latter included actual visit dates, visit type, and
descriptions of the successes and challenges the CRH CQI
mentors encountered in implementing CQI.
Data collection from clusters commenced on 15 July
2015 and concluded on 30 January 2017. Each cluster
contributed pre-exposure data until rolled over to the
CQI intervention. Data collection continued from all
clusters throughout the study until project end, provi-
ding pre-exposure, transition phase and post-exposure
outcome data on all clusters.
As women were recruited at delivery or thereafter
starting on 15 July 2015 - with retrospective capturing of
their routine antenatal care data – the 2-month baseline
data collection period contributed an additional observa-
tion period of ~ 6 months, resulting in a total data col-
lection period of ~ 19 months and total observation
period of ~ 25 months. The final post-exposure period
(after all clusters had received the intervention) was
4.5 months (Fig. 2).
Eleven data clerks trained in International Conference on
Harmonisation (ICH) Good Clinical Practice (GCP) guide-
lines were based at either Hlabisa Hospital or the 7 PHCs
throughout the study. All data collected in clinics and Hla-
bisa Hospital, including cameras, were returned daily to the
AHRI data centre for secure storage and capturing. A data
capturing team of five trained in ICH GCP, including
research nurses and quality controllers, captured clinical
and laboratory data from digital photographs of MCRs and
infant RtHB, and all information from structured question-
naires onto a REDCap™ study database [39].
Table 2 Description of CQI tools used in the intervention
CQI tool Description
Process map A map of clinic processes relating to a specific activity from the time a patient walks into the clinic
A map, including waiting times and waiting site, is created for each activity as there may be differences in the process based on
clinical need (e.g. a patient who is HIV-positive with tuberculosis co-infection versus a patient who is HIV-positive without
tuberculosis). Mapping identifies areas for improved process efficiency, thereby reducing clinical workload and patient
waiting times.
Run chart A display of real-time data on target indicators
The run chart is the essence of the ‘data-driven’ approach of CQI. Target indicators, or process indicators, are selected during the
early stages of CQI implementation, for monitoring throughout the period of CQI activities. Facility staff can observe the results
of changed activities using their own data in real-time on the so-called run chart. The run chart facilitates motivation and buy-in.
Fishbone diagram A diagrammatic representation of factors contributing to a specific clinical endpoint – a ‘cause and effect’ diagram
PDSA cycle [44] A representation of the process of change
In the Planning stage, facility staff (guided by CRH CQI mentors) plan how to implement change targeting a specific endpoint
(Plan). This is followed by actual implementation (Do) and review of progress and challenges (Study). The change becomes
embedded in normal practice if implementation was successful, or generates a different method of implementation (Act).
CQI Continuous Quality Improvement, CRH Centre for Rural Health, PDSA Plan-Do-Study-Act
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Randomisation and blinding
Each clinic was a cluster, with the exception of the two
smallest clinics, which jointly formed one cluster. After
a baseline data collection period of 2 months, the first
cluster crossed over from control to intervention expo-
sure state on 29 September 2015; subsequently, one add-
itional cluster crossed over every 2 months (Fig. 2). The
six clusters were divided into 3 groups by patient volume
(low, medium and high). To increase the likelihood that
the sample sizes in intervention and control exposure
states were similar, and to improve balance, we then ran-
domised the clusters to the six calendar sequences of
crossing over, such that both the first three and the last
three sequences included one small, one medium, and one
large cluster. A senior biostatistician performed rando-
misation for all clusters prior to the first intervention step.
All study implementers, evaluators and clinic health
workers were blinded to the initial randomisation status.
Two weeks prior to each scheduled intervention step
crossover date, the custodian of the randomisation list
(AHRI Chief Information Officer) revealed the rando-
mised cluster to the AHRI study team. The AHRI study
team then introduced the CRH team to the randomised
cluster for CQI training to commence.
Analysis
Power calculation
For our baseline power calculation, we assumed – based
on local routine primary care data – that without the
MONARCH intervention viral load testing would be
carried out in 40% of all pregnant women who were
HIV-positive and repeat HIV testing would be carried
out in 65% of all pregnant women who were
HIV-negative. Based on local routine primary care data,
we further assumed that half of all pregnant women
would be HIV-positive and that pregnant women would
make three ANC visits. We assumed an intracluster
correlation coefficient (ICC) of 0.10. This coefficient is
conservative compared to ICCs that we empirically mea-
sured in a similar setting (PHCs in sub-Saharan Africa
providing ANC and HIV treatment and care), which
ranged from 0.00 to 0.07 [40]. Finally, we assumed that
we could not use information from 15% of enrolled
women because of missing data. Given these assump-
tions, we estimated that we would have 80% power to
detect at least a 15 percentage point increase in our two
primary endpoints at the 5% significance level if we en-
rolled a total of 1260 pregnant women (i.e., 630 women
who were HIV-positive and 630 women who were
HIV-negative). Additional file 1: Table S1 shows the
minimum detectable differences for this sample size with
a number of alternative ICCs and endpoint values in the
control exposure state.
Statistical analysis
The data will be analyzed by intention-to-treat (ITT). For
ITT analyses, patient outcomes will be analyzed by the
exposure status of the clinic attended at the first antenatal
booking visit, independent of later clinic switches. We will
analyse the CQI effect using mixed effects generalized
linear regression models. In the main analysis, we will
include a fixed effect for the time step and a random effect
for clinic, following Hussey and Hughes [41], as well as
adjust for clustering of standard errors at the clinic level.
For the analyses of our two primary endpoints, which are
binary, we will use modified Poisson regression [42] within
the generalized linear regression framework. Our main
results will thus be expressed as risk ratios. In sensitivity
analyses, we will adjust for patient pre-exposure character-
istics, and we will assess effect modification by secular
time and time since intervention start in a clinic [43].
Stata (version 15.0, StataCorp, College Station, Texas) will
be used for all analyses.
Process evaluation
For the Process Evaluation we will use a logic framework
to explore the relationship between (i) input factors or
resources that guide; (ii) activities needed to transform
inputs into outputs processes; (iii) output elements com-
prising health service products produced with the inputs
and activities; and (iv) the outcomes of this change
process. A SPIRIT checklist pertaining to this protocol is
attached (Additional file 2).
Discussion
The MONARCH stepped-wedge RCT is the first trial to
determine the effectiveness of an intervention to in-
crease testing for health indicators among pregnant
women that are critical for good health outcomes in
HIV hyperendemic communities: VL testing among
pregnant women who are HIV-positive and repeat HIV
testing among pregnant women who are HIV-negative.
The MONARCH study is also one of the first to mea-
sure the causal effect of CQI on ANC and PNC services
in sub-Saharan Africa.
The MONARCH trial was embedded within the public
health system and implemented within routinely available
resources including the physical infrastructure of primary
care clinics, data systems, and human resources. The suc-
cess of the CQI intervention depends not only on this
context, including staff motivation and the other resources
available to change clinical processes. One of the advan-
tages of CQI is that it leads to a selection of actions that
can lead to successful improvements given the local abil-
ities and constraints. Through local data collection and
clinic-specific analysis health workers are empowered to
identify the root causes of existing shortcomings; through
small-scale tests in PDSA cycles they can develop the
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locally best solutions to address these shortcomings. The
iterative manner in which CQI unfolds ensures that candi-
date solutions are repeatedly tested and modified until ro-
bust and sustainable approaches have been identified [44,
45]. Given significant resource constraints, it is particu-
larly important to understand the mechanisms of the lo-
cally developed approaches and the determinants of their
success. The Process Evaluation, which was nested in this
trial, will therefore be highly informative in understanding
the implementation of this complex intervention.
The MONARCH trial has several limitations. First, it
took place in a real-life setting where normal service
delivery and targets had to be met during CQI implemen-
tation – this may have limited the availability of healthcare
providers to participate in the intervention. This test of
the effectiveness of CQI was thus a test of CQI “in real
life” and we cannot conclude from a null finding that CQI
cannot be highly effective in a context with fewer outside
pressures and more resource commitments. Second, ad-
vertisement of the study to DoH sub-district and facility
staff prior to MONARCH study start may have driven
changes towards endpoint targets and biased impact
evaluation towards the null. Finally, the health workers in
the control clusters might have learned about CQI
methods and approaches to improve endpoint attainment
from the health workers in the intervention clusters, also
resulting in bias towards the null. Conversely, our efforts
to reduce such contamination – such as blinding health
workers to the randomisation status of their clinic and
instructing the CQI mentors not to suggest solutions de-
veloped by previous clinic teams in their interactions with
new clinic teams until post-randomisation – run counter
to the philosophy of CQI, which includes sharing of solu-
tions and approaches between CQI teams. These mea-
sures, which increase the validity of the trial, may have
reduced the effectiveness of the CQI intervention that we
have tested.
Overall, we expect that the results of the MONARCH
trial and nested process evaluation will be useful for
policy makers and practitioners seeking to increase the
quality of care for pregnant women in HIV hyperen-
demic communities. It will also be useful for health
systems managers striving to improve quality of primary
care in severely resource-constrained clinics. Study re-
sults will be shared with local and regional policy makers
during policy engagement workshops and presentations.
We will also disseminate our results via peer-reviewed
journals and presentations at scientific conferences.
Trial status
The study commenced in mid-July 2015 and ended on
30 January 2017. At the time of submission of the manu-
script, no other articles pertaining to the protocol are
published or under consideration for publication.
Additional files
Additional file 1: MONARCH SWT protocol. Text S1: South African
National Department of Health standard of care: PMTCT guidelines and
basic antenatal care. Table S1. Minimum detectable differences in
percentage points by outcome. (DOCX 25 kb)
Additional file 2: MONARCH SWT protocol. Description of data: SPIRIT
checklist. (DOCX 28 kb)
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